SG11201807352XA - Novel alpha-1-microglobulin derived proteins and their use - Google Patents
Novel alpha-1-microglobulin derived proteins and their useInfo
- Publication number
- SG11201807352XA SG11201807352XA SG11201807352XA SG11201807352XA SG11201807352XA SG 11201807352X A SG11201807352X A SG 11201807352XA SG 11201807352X A SG11201807352X A SG 11201807352XA SG 11201807352X A SG11201807352X A SG 11201807352XA SG 11201807352X A SG11201807352X A SG 11201807352XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- lund
- pct
- english
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization MD 1111101110101011111 01011111011101101111111011111101111111011 III International Bureau .. ..... ..Yi j (10) International Publication Number (43) International Publication Date .... ...,,, WO 2017/158181 Al 21 September 2017 (21.09.2017) WIP0 I PCT (51) International Patent Classification: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, CO7K 14/47 (2006.01) NI, RU, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (21) International Application Number: PCT/EP2017/056436 TH, ZA, ZM, ZW. TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (22) International Filing Date: (84) Designated States (unless otherwise indicated, for every 17 March 2017 (17.03.2017) kind of regional protection available): ARIPO (BW, GH, (25) Filing Language: English GM, TZ, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (26) Publication Language: English TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (30) Priority Data: PA 2016 70158 18 March 2016 (18.03.2016) DK DK, LV, SM, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (71) Applicant: AIM PHARMA AB [SE/SE]; Scheelevagen 22, 223 63 Lund (SE). GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: (72) Inventors: ROSENLOF, Lena Wester; Banvallsvagen 17, 242 93 Horby (SE). HAGERWALL, Anneli Edstrom; as to applicant's entitlement to apply for and be granted a Staffans Grand 6A, 222 23 Lund (SE). AKERSTROM, patent (Rule 4.17(ii)) Bo; Skordevagen 3, 227 38 Lund (SE). — of inventorship (Rule 4.17(iv)) — (74) Agent: CHAS. HUDE A/S; H.C. Andersens Boulevard 33, 1780 Kobenhavn V (DK). Published: — with international search report (Art. 21(3)) = (81) Designated States (unless otherwise indicated, for every _ before the expiration of the time limit for amending the kind of national protection available): AE, AG, AL, AM, claims and to be republished in the event of receipt of = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) = — = = = = = = = = = = 1-1 Il GC Il cc kin ,-1 IN ,-1 © ei C (54) Title: NOVEL ALPHA-1-MICROGLOBULIN DERIVED PROTEINS AND THEIR USE (57) : This invention relates to an alpha-1-microglobulin derived protein for medical use.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201670158 | 2016-03-18 | ||
| PCT/EP2017/056436 WO2017158181A1 (en) | 2016-03-18 | 2017-03-17 | Novel alpha-1-microglobulin derived proteins and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807352XA true SG11201807352XA (en) | 2018-09-27 |
Family
ID=56080208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807352XA SG11201807352XA (en) | 2016-03-18 | 2017-03-17 | Novel alpha-1-microglobulin derived proteins and their use |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10981963B2 (en) |
| EP (1) | EP3430032B1 (en) |
| JP (1) | JP6976579B2 (en) |
| KR (1) | KR102437662B1 (en) |
| CN (1) | CN108779157B (en) |
| AU (1) | AU2017235608B2 (en) |
| BR (1) | BR112018068522A2 (en) |
| CA (1) | CA3017836A1 (en) |
| EA (1) | EA039776B1 (en) |
| ES (1) | ES2896734T3 (en) |
| MX (1) | MX2018011193A (en) |
| NZ (1) | NZ746677A (en) |
| SG (1) | SG11201807352XA (en) |
| WO (1) | WO2017158181A1 (en) |
| ZA (1) | ZA201805797B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111511386A (en) * | 2017-11-03 | 2020-08-07 | 卫士医疗国际公司 | α -1-microglobulin for protecting bone marrow cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2313106B1 (en) * | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
| US9758554B2 (en) * | 2012-01-31 | 2017-09-12 | Technische Universitaet Muenchen | Muteins of α1m lipocalin and method of production therefor |
| HUE030559T2 (en) | 2012-09-05 | 2017-05-29 | A1M Pharma Ab | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
| WO2014047490A1 (en) * | 2012-09-21 | 2014-03-27 | Beintoo, S.P.A. | Interactive experience fully contained within an expandalble embedded unit |
| US10226570B2 (en) * | 2017-03-10 | 2019-03-12 | Seton Healthcare Family | Apparatus and method for temporarily securing a movable accessory device relative to a movable patient |
-
2017
- 2017-03-17 CN CN201780018244.4A patent/CN108779157B/en active Active
- 2017-03-17 AU AU2017235608A patent/AU2017235608B2/en active Active
- 2017-03-17 US US16/085,500 patent/US10981963B2/en active Active
- 2017-03-17 ES ES17711205T patent/ES2896734T3/en active Active
- 2017-03-17 EA EA201892085A patent/EA039776B1/en unknown
- 2017-03-17 SG SG11201807352XA patent/SG11201807352XA/en unknown
- 2017-03-17 BR BR112018068522A patent/BR112018068522A2/en unknown
- 2017-03-17 WO PCT/EP2017/056436 patent/WO2017158181A1/en active Application Filing
- 2017-03-17 MX MX2018011193A patent/MX2018011193A/en unknown
- 2017-03-17 NZ NZ746677A patent/NZ746677A/en unknown
- 2017-03-17 KR KR1020187029939A patent/KR102437662B1/en active IP Right Grant
- 2017-03-17 EP EP17711205.9A patent/EP3430032B1/en active Active
- 2017-03-17 JP JP2018548761A patent/JP6976579B2/en active Active
- 2017-03-17 CA CA3017836A patent/CA3017836A1/en active Pending
-
2018
- 2018-08-29 ZA ZA2018/05797A patent/ZA201805797B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10981963B2 (en) | 2021-04-20 |
| EA201892085A1 (en) | 2019-02-28 |
| WO2017158181A1 (en) | 2017-09-21 |
| KR102437662B1 (en) | 2022-08-29 |
| BR112018068522A2 (en) | 2019-01-22 |
| EP3430032A1 (en) | 2019-01-23 |
| MX2018011193A (en) | 2019-03-28 |
| EA039776B1 (en) | 2022-03-11 |
| ZA201805797B (en) | 2022-03-30 |
| EP3430032B1 (en) | 2021-09-01 |
| US20190161524A1 (en) | 2019-05-30 |
| CA3017836A1 (en) | 2017-09-21 |
| CN108779157A (en) | 2018-11-09 |
| NZ746677A (en) | 2023-02-24 |
| JP2019519466A (en) | 2019-07-11 |
| KR20180127411A (en) | 2018-11-28 |
| CN108779157B (en) | 2022-12-30 |
| ES2896734T3 (en) | 2022-02-25 |
| JP6976579B2 (en) | 2021-12-08 |
| AU2017235608B2 (en) | 2020-10-22 |
| AU2017235608A1 (en) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201804373VA (en) | Compositions and methods for immunooncology | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201811432WA (en) | Rna for cancer therapy | |
| SG11201901206SA (en) | Trimer stabilizing hiv envelope protein mutations | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201806863WA (en) | Tetracyclic pyridone compounds as antivirals | |
| SG11201805320XA (en) | Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration | |
| SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201806342SA (en) | Glucagon and glp-1 co-agonists for the treatment of obesity | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201811230RA (en) | Compositions and methods for reducing ocular neovascularization | |
| SG11201810371XA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201909680UA (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof |